| Nome |
# |
|
Exploring the genetics of irritable bowel syndrome: A GWA study in the general population and replication in multinational case-control cohorts, file e14fb268-3c4c-3de1-e053-1705fe0ac030
|
317
|
|
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy, file e14fb26b-9f04-3de1-e053-1705fe0ac030
|
279
|
|
Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis, file e14fb269-503f-3de1-e053-1705fe0ac030
|
211
|
|
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?, file e14fb26d-1557-3de1-e053-1705fe0ac030
|
180
|
|
Anti-inflammatory effect of a novel locally acting A2Areceptor agonist in a rat model of oxazolone-induced colitis, file e14fb26a-8516-3de1-e053-1705fe0ac030
|
167
|
|
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats, file e14fb268-29ff-3de1-e053-1705fe0ac030
|
131
|
|
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation, file e14fb26b-33a9-3de1-e053-1705fe0ac030
|
123
|
|
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration, file e14fb269-47d5-3de1-e053-1705fe0ac030
|
122
|
|
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration, file e14fb26c-8902-3de1-e053-1705fe0ac030
|
121
|
|
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic, file e14fb268-3984-3de1-e053-1705fe0ac030
|
120
|
|
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis, file e14fb268-2c96-3de1-e053-1705fe0ac030
|
116
|
|
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity, file e14fb26a-f0f2-3de1-e053-1705fe0ac030
|
115
|
|
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity, file e14fb26b-7058-3de1-e053-1705fe0ac030
|
102
|
|
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?, file e14fb26a-f0f0-3de1-e053-1705fe0ac030
|
89
|
|
Microvascular endothelial dysfunction in human obesity: role of TNF-α, file e14fb26b-2b11-3de1-e053-1705fe0ac030
|
84
|
|
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention, file e14fb26b-33ad-3de1-e053-1705fe0ac030
|
71
|
|
Intestinal epithelial barrier and neuromuscular compartment in health and disease, file e14fb26d-2e26-3de1-e053-1705fe0ac030
|
70
|
|
A 2,3-diphenylpyrido[1,2-a] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-alpha, file e14fb26c-5dca-3de1-e053-1705fe0ac030
|
64
|
|
Effects of maternal obesity and direct exposure to high-fat diet on bowel functions in offsprings, file e14fb26d-3c8b-3de1-e053-1705fe0ac030
|
40
|
|
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity, file e14fb26e-ba90-3de1-e053-1705fe0ac030
|
39
|
|
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review, file e14fb268-311a-3de1-e053-1705fe0ac030
|
35
|
|
Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence, file e14fb268-1f16-3de1-e053-1705fe0ac030
|
29
|
|
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia, file e14fb26c-8b18-3de1-e053-1705fe0ac030
|
28
|
|
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders, file e14fb268-2782-3de1-e053-1705fe0ac030
|
25
|
|
Use of serotonin re-uptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update, file e14fb268-2ff3-3de1-e053-1705fe0ac030
|
25
|
|
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing, file e14fb268-3e5e-3de1-e053-1705fe0ac030
|
23
|
|
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders, file e14fb268-3c4a-3de1-e053-1705fe0ac030
|
22
|
|
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction, file e14fb268-3ab9-3de1-e053-1705fe0ac030
|
20
|
|
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage, file e14fb268-447e-3de1-e053-1705fe0ac030
|
20
|
|
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models, file e14fb269-5364-3de1-e053-1705fe0ac030
|
19
|
|
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications, file e14fb268-3e5c-3de1-e053-1705fe0ac030
|
18
|
|
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review, file e14fb268-3abe-3de1-e053-1705fe0ac030
|
17
|
|
Microvascular Endothelial Dysfunction in Patients with Obesity, file e14fb26b-a24a-3de1-e053-1705fe0ac030
|
17
|
|
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders, file e14fb268-2ba7-3de1-e053-1705fe0ac030
|
15
|
|
Adenosine and inflammation: what's new on the horizon?, file e14fb268-3c4e-3de1-e053-1705fe0ac030
|
15
|
|
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration, file e14fb269-d947-3de1-e053-1705fe0ac030
|
15
|
|
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role, file e14fb268-2423-3de1-e053-1705fe0ac030
|
13
|
|
Adenosine pathway and cancer: Where do we go from here?, file e14fb268-2dc6-3de1-e053-1705fe0ac030
|
13
|
|
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy, file e14fb268-2fe5-3de1-e053-1705fe0ac030
|
13
|
|
CCK-1 and CCK-2 receptors regulate gastric pepsinogen secretion, file e14fb268-1d07-3de1-e053-1705fe0ac030
|
12
|
|
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress, file e14fb268-1de0-3de1-e053-1705fe0ac030
|
12
|
|
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon, file e14fb268-1f8d-3de1-e053-1705fe0ac030
|
12
|
|
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis, file e14fb268-3ab6-3de1-e053-1705fe0ac030
|
12
|
|
Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy, file e14fb26d-1c19-3de1-e053-1705fe0ac030
|
12
|
|
The effects of obesity superimposed with aging in female mouse model, file e14fb26d-4a4a-3de1-e053-1705fe0ac030
|
12
|
|
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation, file e14fb26e-d7dc-3de1-e053-1705fe0ac030
|
12
|
|
Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats., file e14fb268-2496-3de1-e053-1705fe0ac030
|
11
|
|
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients, file e14fb268-311b-3de1-e053-1705fe0ac030
|
11
|
|
H3 receptor-mediated inhibition of intestinal acetylcholine release: pharmacological characterization of signal transduction pathways, file e14fb268-4486-3de1-e053-1705fe0ac030
|
11
|
|
Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?, file e14fb268-246e-3de1-e053-1705fe0ac030
|
10
|
|
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions, file e14fb268-2472-3de1-e053-1705fe0ac030
|
10
|
|
Altered expression pattern of molecular factors involved in colonic smooth muscle functions: an immunohistochemical study in patients with diverticular disease, file e14fb268-2786-3de1-e053-1705fe0ac030
|
10
|
|
Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury, file e14fb268-1d02-3de1-e053-1705fe0ac030
|
9
|
|
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis, file e14fb268-1f1b-3de1-e053-1705fe0ac030
|
9
|
|
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron, file e14fb268-26ce-3de1-e053-1705fe0ac030
|
9
|
|
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases, file e14fb268-2781-3de1-e053-1705fe0ac030
|
9
|
|
Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats, file e14fb268-2d96-3de1-e053-1705fe0ac030
|
9
|
|
Role of cyclooxygenase-2 in the proliferative activity of gastrin on human colon cancer cells, file e14fb268-2e70-3de1-e053-1705fe0ac030
|
9
|
|
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon, file e14fb268-1fd4-3de1-e053-1705fe0ac030
|
8
|
|
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment, file e14fb268-2475-3de1-e053-1705fe0ac030
|
8
|
|
Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications, file e14fb268-2780-3de1-e053-1705fe0ac030
|
8
|
|
Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds, file e14fb268-3abc-3de1-e053-1705fe0ac030
|
8
|
|
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists, file e14fb268-3ed2-3de1-e053-1705fe0ac030
|
8
|
|
Enteric Protective Effects of the Combination Bifidobacterium Longum and Lactoferrin in a Rat Model of Diclofenac-Induced Intestinal Injury, file e14fb26a-a771-3de1-e053-1705fe0ac030
|
8
|
|
The ecto-enzymes CD73 and adenosine deaminase modulate 5′-AMP-derived adenosine in myofibroblasts of the rat small intestine, file e14fb26b-1af9-3de1-e053-1705fe0ac030
|
8
|
|
Pathophysiology of Gastric Ulcer Development and Healing: Molecular Mechanisms and Novel Therapeutic Options, file e14fb26c-4248-3de1-e053-1705fe0ac030
|
8
|
|
Histamine H3 receptors mediate inhibition of noradrenaline release from intestinal sympathetic nerves, file e14fb268-241b-3de1-e053-1705fe0ac030
|
7
|
|
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment, file e14fb268-2fe2-3de1-e053-1705fe0ac030
|
7
|
|
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition, file e14fb268-3c52-3de1-e053-1705fe0ac030
|
7
|
|
Characterization of alpha-2-adrenoceptor subtypes involved in the modulation of gastric acid secretion, file e14fb268-3f60-3de1-e053-1705fe0ac030
|
7
|
|
Central administration of cholecystokinin stimulates gastric pepsinogen secretion from anaesthetized rats., file e14fb268-3fd4-3de1-e053-1705fe0ac030
|
7
|
|
Derivatives of benzimidazol-2-ylquinoline and benzimidazol-2-ylisoquinoline as selective A1 adenosine receptor antagonists with stimulant activity on human colon motility, file e14fb268-1f1a-3de1-e053-1705fe0ac030
|
6
|
|
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis, file e14fb268-1fcd-3de1-e053-1705fe0ac030
|
6
|
|
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation, file e14fb268-1fce-3de1-e053-1705fe0ac030
|
6
|
|
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon, file e14fb268-1fd2-3de1-e053-1705fe0ac030
|
6
|
|
Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review, file e14fb268-1fd5-3de1-e053-1705fe0ac030
|
6
|
|
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: A preclinical study, file e14fb268-2409-3de1-e053-1705fe0ac030
|
6
|
|
Somatostatin modulates both cyclooxygenase-2 expression and proliferation in human colon cancer cells, file e14fb268-29f5-3de1-e053-1705fe0ac030
|
6
|
|
Alterations of Colonic Neuromuscular Excitatory Cholinergic Pathway in a Rat Model of 6-Hydroxydopamine-Induced Parkinson's Disease, file e14fb268-2bb2-3de1-e053-1705fe0ac030
|
6
|
|
398 Rifaximin Displays a Protective Activity in Experimental Enteropathy Induced by Indomethacin in Rats, file e14fb268-2d81-3de1-e053-1705fe0ac030
|
6
|
|
Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase, file e14fb268-2dbe-3de1-e053-1705fe0ac030
|
6
|
|
Review article: Molecular, pathological and therapeutic features of human enteric neuropathies, file e14fb268-2ff7-3de1-e053-1705fe0ac030
|
6
|
|
Immunohistochemical Analysis of Myenteric Ganglia and Interstitial Cells of Cajal in Ulcerative Colitis, file e14fb268-3c54-3de1-e053-1705fe0ac030
|
6
|
|
The β3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats, file e14fb268-3d66-3de1-e053-1705fe0ac030
|
6
|
|
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome, file e14fb268-3e5a-3de1-e053-1705fe0ac030
|
6
|
|
Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha-2adrenoceptors or imidazoline receptors?, file e14fb268-3edb-3de1-e053-1705fe0ac030
|
6
|
|
Role of peripheral GABAB receptors in the regulation of pepsinogen secretion in anaesthetized rats, file e14fb268-3f5e-3de1-e053-1705fe0ac030
|
6
|
|
Determination on functional basis of presynaptic alpha2-adrenoceptor subtypes in guinea-pig duodenum, file e14fb268-400c-3de1-e053-1705fe0ac030
|
6
|
|
L-histidine decarboxylase decreases its own transcription through downregulation of ERK activity, file e14fb268-4481-3de1-e053-1705fe0ac030
|
6
|
|
Sa1694 Colonic Inflammation in Experimental Parkinson's Disease: Evidence of Altered Colonic Tachykininergic Neurotransmissio, file e14fb269-4ebd-3de1-e053-1705fe0ac030
|
6
|
|
Central GABA-A receptors exert a tonic inhibitory control on gastric pepsinogen secretion in anaesthetized rats, file e14fb269-7810-3de1-e053-1705fe0ac030
|
6
|
|
Prodromal intestinal events in alzheimer’s disease (Ad): Colonic dysmotility and inflammation are associated with enteric ad-related protein deposition, file e14fb26d-4dcf-3de1-e053-1705fe0ac030
|
6
|
|
Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis, file e14fb268-1d12-3de1-e053-1705fe0ac030
|
5
|
|
Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan., file e14fb268-2422-3de1-e053-1705fe0ac030
|
5
|
|
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms, file e14fb268-2470-3de1-e053-1705fe0ac030
|
5
|
|
The genetics of human serotonin transporter and irritable bowel syndrome, file e14fb268-27c7-3de1-e053-1705fe0ac030
|
5
|
|
SU2045 Characterization of Excitatory and Inhibitory Neuromuscolar Pathways Regulating Colonic Motility in a Rat Model of Parkinson's Disease, file e14fb268-2bb6-3de1-e053-1705fe0ac030
|
5
|
|
Mo2044 Irritable Bowel Syndrome, Serotonin Transporter 5HTTLPR Polymorphism and Psychopathological Traits: Dangerous Relations?, file e14fb268-2e6e-3de1-e053-1705fe0ac030
|
5
|
|
Mo1810 Cyclooxygenase Inhibitors Counteract PRO-Fibrotic Signalling in Experimental Colitis Through Modulation of TGF-Beta/SMAD Network, file e14fb268-30d8-3de1-e053-1705fe0ac030
|
5
|
|
Suramin enhances ethanol-induced injury to gastric mucosa in rats., file e14fb268-3fd8-3de1-e053-1705fe0ac030
|
5
|
| Totale |
3.409 |